# Rani Therapeutics

**Canonical:** https://apis.io/providers/rani-therapeutics/  
**Website:** https://ranitherapeutics.com  
**APIs profiled:** 0

Rani Therapeutics is a clinical-stage biotechnology company developing the RaniPill, an ingestible robotic capsule engineered to deliver biologic drugs orally in place of subcutaneous or intravenous injections. The platform aims to preserve injection-comparable bioavailability while removing the pain and adherence barriers of needle-based therapies across chronic and metabolic disease areas. Surfaced as a portfolio company of GV and added to the API Evangelist network; the company is a publicly traded life-sciences firm and does not currently publish a developer API, developer portal, or programmatic data surface.

## Kin Score — 6.2 / 100 (minimal)

Scored 2026-08-21 under rubric 0.12.0. Trend: flat (+0.0 from 6.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Rani Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Life Sciences, Biotechnology, Pharmaceuticals, Drug Delivery, Biologics, Clinical Stage

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/rani-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.